BIOMAT Database Logo BIOMAT Database Logo

[THE ANTIBACTERIAL ACTION OF KANAMYCIN IN VITRO AND ITS CHEMOTHERAPEUTIC ACTIVITY]. 1964

V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER

UI MeSH Term Description Entries
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D007709 Klebsiella A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D011512 Proteus Infections Infections with bacteria of the genus PROTEUS. Infections, Proteus,Infection, Proteus,Proteus Infection
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[Preliminary observations on the antibacterial activity of kanamycin in vitro & on its action in human tuberculosis].
January 1958, Giornale italiano della tubercolosi,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
September 1968, Antibiotiki,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[Kanamycin: study of its antibacterial activity].
April 1959, La Riforma medica,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine].
December 1964, Bollettino della Societa italiana di biologia sperimentale,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[Antibacterial action of kanamycin].
June 1959, Medicina,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
Antibacterial activity of Kanamycin.
March 1958, Antibiotics & chemotherapy (Northfield, Ill.),
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[Antibacterial activity in vitro and in vivo of a new kanamycin: BBK-8].
January 1974, Antibiotica,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
The chemotherapeutic action of phenanthridine compounds. IV. Activity in vitro.
September 1950, British journal of pharmacology and chemotherapy,
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
Laboratory studies on the antibacterial activity of kanamycin.
August 1959, Antibiotics & chemotherapy (Northfield, Ill.),
V A SHORIN, and S P SHAPOVALOVA, and N S PEVZNER
[The activity of kanamycin on the growth curve of Mycobacterium tuberculosis. Note 2. Action of kanamycin associated with other antibacterial agents].
March 1960, Giornale di clinica medica,
Copied contents to your clipboard!